 |
|
U-Iowa improves delivery of cancer-fighting molecules
August 28, 2009Small interfering RNA (siRNA), a type of genetic material, can block potentially harmful activity in cells, such as tumor cell growth. But delivering siRNA successfully to specific cells without adversely affecting other cells has been challenging.
University of Iowa researchers have modified siRNA so that it can be injected into the bloodstream and impact targeted cells while producing fewer side effects. The findings, which were based on animal models of prostate cancer, also could make it easier to create large amounts of targeted therapeutic siRNAs for treating cancer and other diseases. The study results appeared online Aug. 23 in the journal Nature Biotechnology.
"Our goal was to make siRNA deliverable through the bloodstream and make it more specific to the genes that are over expressed in cancer," said the study's senior author Paloma Giangrande, Ph.D., assistant professor of internal medicine and a member of Holden Comprehensive Cancer Center.
In previous research completed at Duke University, Giangrande's team showed that a compound called an aptamer can be combined with siRNA to target certain genes. When the combined molecule is directly injected into tumors in animal models, it triggers the processes that stop tumor growth. However, directly injecting the combination into tumors in humans is difficult.
In the new study, the researchers trimmed the size of a prostate cancer-specific aptamer and modified the siRNA to increase its activity. Upon injection into the bloodstream, the combination triggered tumor regression without affecting normal tissues.
Making the aptamer-siRNA combination smaller makes it easier to produce large amounts of it synthetically, Giangrande said.
The team also addressed the problem that large amounts of siRNA are needed since most of it gets excreted by the kidneys before having an effect. To keep siRNA in the body longer and thereby use less of it, the team modified it using a process called PEGlyation.
"If you want to use siRNA effectively for clinical use, especially for cancer treatment, you need to deliver it through an injection into the bloodstream, reduce the amount of side effects and be able to improve its cost-effectiveness. Our findings may help make these things possible," Giangrande said.
Although the current study focused on prostate cancer, the findings could apply to other cancers and diseases. Giangrande said the next step is to test the optimized aptamer-siRNA compound in a larger animal model.
University of Iowa
In previous research completed at Duke University, Giangrande's team showed that a compound called an aptamer can be combined with siRNA to target certain genes. When the combined molecule is directly injected into tumors in animal models, it triggers the processes that stop tumor growth. However, directly injecting the combination into tumors in humans is difficult.
In the new study, the researchers trimmed the size of a prostate cancer-specific aptamer and modified the siRNA to increase its activity. Upon injection into the bloodstream, the combination triggered tumor regression without affecting normal tissues.
Making the aptamer-siRNA combination smaller makes it easier to produce large amounts of it synthetically, Giangrande said.
The team also addressed the problem that large amounts of siRNA are needed since most of it gets excreted by the kidneys before having an effect. To keep siRNA in the body longer and thereby use less of it, the team modified it using a process called PEGlyation.
"If you want to use siRNA effectively for clinical use, especially for cancer treatment, you need to deliver it through an injection into the bloodstream, reduce the amount of side effects and be able to improve its cost-effectiveness. Our findings may help make these things possible," Giangrande said.
Although the current study focused on prostate cancer, the findings could apply to other cancers and diseases. Giangrande said the next step is to test the optimized aptamer-siRNA compound in a larger animal model.
University of Iowa
Bloodstream Current Events and Bloodstream News RSSMeasuring and modeling blood flow in malaria
When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
WPI Researchers Take Aim at Hard-to-Treat Fungal Infections
A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections.
UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
Greater certainty in monitoring 3 therapeutic medications is facilitated by new CRMs
To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs).
Routine evaluation of prostate size not as effective in cancer screening, Mayo study finds
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer.
Findings show nanomedicine promising for treating spinal cord injuries
Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident.
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
Hybrid molecules show promise for exploring, treating Alzheimer's
One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.
New class of molecules may help prevent fatal complication in patients with kidney disease
Researchers at the University of Maryland School of Medicine have made an important discovery about why potassium builds up to dangerous levels in the bloodstream, a relatively common medical problem that affects about eight percent of hospitalized patients.
More Bloodstream Current Events and Bloodstream News Articles
 |
Bloodstream by Tess Gerritsen (Author) With her acclaimed novels Harvest and Life Support, Tess Gerritsen has injected a powerful dose of adrenaline into the medical thriller. Now, in a new blockbuster, Gerritsen melds page-turning suspense with chilling realism as a small-town doctor races to unravel the roots of a violent outbreak -- before it destroys everything she loves. Lapped by he gentle waters of Locust Lake, the small resort town of Tranquility, Maine, seems like the perfect spot for Dr. Claire Elliot to shelter her adolescent son, Noah, from the distractions of the big city and the lingering memory of his father's death. But with the first snap of winter comes shocking news that puts her practise on the line: a teenage boy under her care has committed an appalling act of violence. And as Claire and all of... |
|
The Bloodstream : River of Life by Isaac Asimov (Author) | |
 |
Bloodstream Stateless (Primary Contributor) |
 |
Apocalypse in Retrospect by Bloodstream Parade |
|
Bloodstream by Tess Gerritsen (Author) | |
 |
Botanic Choice Dandelion Capsules Bottles (Pack of 6) by Botanic Choice If you have only thought of dandelion as a weed, think again. It has traditionally been used to promote overall health. The roots are used as a liver tonic, blood cleanser and digestive stimulant. A natural diuretic and power-packed with iron, dandelion helps your body remove toxins and excess fluids.Enjoy the benefits that Dandelion has to offer. |
 |
1955 Union Carbide Atoms Radioisotopes Bloodstream Print Ad by AdsPast.com An original vintage magazine ad print from the year published. Print ads make unique gift items that can be framed as artwork. Shipped flat un-framed in plastic sleeve with backing board. |
|
The Bloodstream by Issac Asimov (Author) | |
 |
Journey to the Center of the Bat! Also With: Warner Bros. (Producer) |
|
Bloodstream by tess gerritsen (Author), Richard Poe (Narrator) Dr. Claire Elliott and her teenage son Noah have just moved from the big city to Tranquility, Maine, in search of solace after the death of Noah's father. But as the winter chill begins to blanket this tiny hamlet, Claire discovers that her new home is anything but tranquil. A teenage boy under her care has just committed a terrifying act-one that ignites a chain of atrocities committed by local youths. Frightened for her life, as well as her son's, Claire begins her own investigation that uncovers an epidemic of teenage violence that occurs twice every century in Tranquility. Is the cause of the epidemic a natural foe, or is there a manmade conspiracy behind the nightmare? It's up to Claire to find the truth before it's too late. |
| © 2009 BrightSurf.com |